OCULUS INNOVATIVE SCIENCES, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Exhibit 4.6
THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this “Agreement”) is made and
entered into effective as of the 14th day of September, 2006, by and among (i) Oculus
Innovative Sciences, Inc., a California corporation (the “Company”), (ii) those parties
(each an “Existing Series A Investor” and collectively the “Existing Series A
Investors”) listed on Schedule A attached to that certain Series A Preferred Shares Investors’
Rights Agreement previously entered into by and among such Series A Existing Investors and the
Company (the “Prior Series A XXX”) and those parties (each an “Existing Series B
Investor” and collectively the “Existing Series B Investors”) listed on Schedule A
attached to that certain Series B Preferred Shares Investor Right Agreement (the “Prior Series
B XXX” and, together with the Prior Series A XXX, the “Prior Agreements”), (iii) those
parties as set forth in Schedule A attached hereto (each a “New Investor” and
collectively the “New Investors”), and (iv) the individuals as set forth in Schedule
B attached hereto (each a “Principal Shareholder” and collectively the “Principal
Shareholders”). The Existing Investors and the New Investors are referred to herein
collectively as the “Investors”.
“Board” means the Board of Directors of the Company.
“Change of Control” means (i) the Company’s sale of all or substantially all of its
assets, (ii) any merger, consolidation or other similar transaction involving the Company, where
the shareholders of the Company immediately prior to such transaction fail to hold more than 50% of
the capital stock of the surviving entity immediately following such transaction, or (iii) any
transaction involving the transfer, directly or indirectly, of capital stock of the Company
representing 50% or more of the voting power of the Company.
“Commission” means the Securities and Exchange Commission or any successor agency.
“Common Shares” means the Common Stock of the Company.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“Existing Preemptive Rights” means the preemptive rights held by the Existing
Investors under Section 16 of each of the Prior Agreements.
“Holder” means any person owning of record outstanding Registrable Securities which
have not been sold to the public, or any assignee thereof in accordance with Sections 7 and 13
hereof. In addition, for purposes of Sections 2 through 12 hereof, the term “Holder” shall
also include the Managing Dealer and the parties to whom the rights of the Managing Dealer under
the Managing Dealer Warrants were transferred in accordance with Section 1.3 of each applicable
Managing Dealer Warrant.
“Initial Public Offering” means an initial public offering of securities of the
Company pursuant to a registration statement filed and declared effective under the Securities Act,
upon completion of which the Company has a class of stock that is registered under the Exchange Act
and is listed or quoted on an exchange or quotation system.
“Investor Warrants” means the Warrants to purchase Common Stock of the Company issued
in connection with the issuance of the Series C Preferred.
“Major Shareholder” means any shareholder, as of the applicable date, who is an
officer or director of the Company, or holder of more than 4.9% of the Company’s capital stock on a
fully-diluted basis as calculated by dividing (1) the number of Common Shares and Preferred Shares
held by such holder by (2) the sum of (i) the number of Common Shares outstanding at the applicable
time, plus (ii) the number of Common Shares into which any Preferred Shares outstanding at the
applicable time may be converted at the applicable conversion price then in effect, plus (iii) the
number of Common Shares and Preferred Shares for which any options to purchase, rights to
subscribe, warrants or other derivative equity securities are outstanding or authorized by any duly
adopted stock option plan or other plan of the Company at the applicable time, plus (iv) the number
of Common Shares into which any other convertible or exchangeable securities, including convertible
debt securities, outstanding at the applicable time may be converted or exchanged; provided,
however, that the term “Major Shareholder” shall not include any Holder.
“Managing Dealer” means Brookstreet Securities Corporation, a California corporation.
2
“Managing Dealer Warrants” means those certain warrants issued, as of the applicable
date, to the Managing Dealer pursuant to that certain Managing Dealer Agreements entered into
effective April 19, 2004 and May ___, 2006, each by and between the Company and the Managing Dealer,
each as may be subsequently amended from time to time.
“Parties” means the parties that are signatories of this Agreement or hereafter agree
in writing to be bound by this Agreement; “Party” shall refer to any one of the Parties.
“Permitted Transfers” means (i) any sale or transfer by a Principal Shareholder of
less than 10% of the Shares such Principal Shareholder then owns in a single transaction or series
of related transactions, (ii) any transfer to another Holder, or (iii) any transfer of the Shares
to a Principal Shareholder’s ancestors, descendants or spouse, brother or sister of the Principal
Shareholder, the adopted child or adopted grandchild of the Principal Shareholder, or to a trust or
trusts for the benefit of such Principal Shareholder or such Principal Shareholder’s family members
as described above, or transfers by a Principal Shareholder by devise or descent, in all cases for
estate planning purposes.
“Preferred Shares” means the Series A Preferred Stock, Series B Preferred Stock and
Series C Preferred Stock of the Company, as well as any one or more series of the Preferred Stock
of the Company to be designated as of a future date.
“Principal Shareholders” means the individuals identified in Schedule B
attached hereto, who are, as of the date of this Agreement, Major Shareholders.
“Registrable Securities” means (i) Common Shares issued or issuable upon the
conversion of the Preferred Shares or the Investor Warrants; and (ii) any other Common Shares
issued as (or issuable upon conversion or exercise of any warrant, right or other security which is
issued as) a dividend or other distribution with respect to or in exchange for or replacement of
the Preferred Shares. In addition, for purposes of Sections 2 through 12 hereof, the term
“Registrable Securities” shall also include Common Shares issued or issuable upon the
exercise of the Managing Dealer Warrants. Notwithstanding the foregoing, the term “Registrable
Securities” shall not include any securities (i) sold by a person to the public either pursuant
to a registration statement or Rule 144, or (ii) sold in a private transaction in which the
transferor’s rights under Section 2 or Section 3 of this Agreement are not assigned.
The terms “register,” “registered” and “registration” refer to a
registration effected by preparing and filing a registration statement in compliance with the
Securities Act, and the declaration or ordering of the effectiveness of such registration
statement.
“Registration Expenses” means all reasonable out-of-pocket expenses incurred by the
Company in complying with Sections 2 and 3 hereof, including, without limitation, all registration,
qualification and filing fees, printing expenses, escrow fees, fees and disbursements of counsel
for the Company, blue sky fees and expenses, accounting fees of the Company, and the reasonable
fees and expenses of one special counsel, if any, for the selling Holders, not to exceed $25,000.
“Restricted Securities” has the meaning set forth in Section 12 hereof.
“Securities Act” means the Securities Act of 1933, as amended.
3
“Selling Expenses” means all underwriting discounts, selling commissions and share
transfer taxes applicable to the securities registered by the Holders pursuant to this Agreement
inclusive of all fees and disbursements of counsel for any Holder (excluding amounts specified
under the definition for Registration Expenses).
“Series A Holder” means the holder of any Series A Preferred.
“Series A Preferred” means the Series A Preferred Stock of the Company.
“Series A Director” means the director on the Board whom the holders of Series A
Preferred have a right to elect under the Company’s Articles of Incorporation.
“Series B Director” means the director on the Board whom the holders of Series B
Preferred have a right to elect under the Company’s Articles of Incorporation.
“Series B Holder” means the holder of any Series B Preferred.
“Series B Preferred” means the Series B Preferred Stock of the Company.
“Series C Preferred” means the Series C Preferred Stock of the Company.
“Shares” has the meaning set forth in Section 9 hereof.
4
limit the number of shares to be underwritten, then (i) in the Company’s Initial Public
Offering of Common Shares, the managing underwriter may exclude all Registrable Securities from
such registration involving an underwriting; and (ii) in a registered public offering and
underwriting not involving an Initial Public Offering, limit the number of Registrable Securities
to be included in the registration and underwriting by reducing the number of Registrable
Securities included on behalf of the Holders on a pro rata basis based on the total number of
Registrable Securities entitled to registration held by each Holder; provided, however, that no
Registrable Securities shall be excluded from a registration under this clause (ii) until all other
outstanding securities of the Company held by the Major Shareholders shall have first been excluded
from such registration and underwriting and provided further that in no event may the number of
Registrable Securities to be included in a registration and underwriting other than the Company’s
Initial Public Offering of Common Shares be reduced to less than 30% of the total number of shares
to be included in such registration and underwriting. The Company shall advise all Holders of
Registrable Securities which would otherwise be registered and underwritten pursuant hereto of any
such limitations.
5
6
determines that an amendment to the registration statement or supplement to the prospectus is
advisable before further sales of Registrable Securities should be made, prepare and file as soon
as reasonable with the Commission such amendment to the registration statement or supplement to the
prospectus and promptly notify each Holder of Registrable Securities covered by such registration
statement of the filing of such amendment or supplement to the registration statement or prospectus
as may be necessary to correct any statements or omissions; provided that if the Board of Directors
of the Company determines that amending the registration statement or supplementing the prospectus
might be detrimental to the Company, then, notwithstanding this Section 5.7, the Company may defer
such amendment or supplement for up to 120 days, provided that: (i) the Company shall not use such
right of deferral with respect to any registration statement for more than an aggregate of 120 days
in any 12-month period; and (ii) the number of days the Company is required to keep the
registration statement effective shall be extended by the number of days for which the Company
shall have used such right of deferral;
If a Holder receives a notification from the Company pursuant to this Section 5 that a
registration statement or prospectus contains an untrue statement or omission or that the Company
is exercising its rights pursuant to Section 5.7, then such Holder shall: (i) keep the fact of such
notification and its contents confidential, and (ii) immediately suspend all sales of securities of
the Company and any use of the registration statement or prospectus as to which the notification
applies, until such time as such Holder receives notification from the Company that an amendment to
the registration statement or a supplement to the prospectus has been filed and that sales may be
made.
7
assigned to any transferee or assignee of Restricted Securities unless the transferee agrees
to be bound by the terms and conditions of this Agreement and the Company receives written notice
within twenty (20) days after such transfer.
8
information furnished to the Company by or on behalf of such Holder and stated to be
specifically for use therein; provided, however, that the obligations of any such Holder hereunder
shall be limited to an amount equal to the gross proceeds before expenses and commissions to such
Holder of Registrable Securities sold as contemplated herein.
9
an Indemnifying Party under Section 8.4, such Indemnified Party shall notify the Indemnifying
Party in writing of the commencement thereof if the notice specified in Section 8.3 has not been
given with respect to such action; provided that the omission so to notify the Indemnifying Party
shall not relieve the Indemnifying Party from any liability which it may have to any Indemnified
Party otherwise under Section 8.4, except to the extent that the Indemnifying Party is actually
prejudiced by such failure to give notice. The parties hereto agree with each other and shall
agree with the underwriters of the Common Shares of the Company pursuant to the terms hereof, if
requested by such underwriters, that (i) the underwriters’ portion of such contribution shall not
exceed the underwriting discount, commission and other compensation, and (ii) the amount of such
contribution shall not exceed an amount equal to the proceeds received by such Indemnifying Party
from the sale of securities in the offering to which the losses, claims, damages or liabilities of
the indemnified parties relate. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation.
10
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION UNDER THE SECURITIES ACT OF
1933, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS
NOT REQUIRED. THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN
AGREEMENT RESTRICTING THEIR TRANSFER, A COPY OF WHICH IS ON FILE AT THE OFFICE OF
THE COMPANY AND WILL BE FURNISHED TO ANY PROSPECTIVE PURCHASERS ON REQUEST. THE
AGREEMENT PROVIDES, AMONG OTHER THINGS, FOR CERTAIN RESTRICTIONS ON THE SALE,
TRANSFER, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SHARES REPRESENTED BY
THIS CERTIFICATE.
11
(1) Each Holder will have the right to sell, on the terms and to the proposed transferee
described in the Selling Principal Shareholder’s Notice, that number of Shares equal to the product
obtained by multiplying (i) the aggregate number of Offered Shares by (ii) a fraction, the
numerator of which is the number of Shares then held by such Holder, and the denominator of which
is the total combined number of Shares then held by the Selling Principal Shareholder (including
shares transferred pursuant to Permitted Transfers by such
12
selling Principal Shareholder in accordance herewith) and the number of Shares issued or
issuable to all Holders that desire to exercise their co-sale rights pursuant to this Section 15.
For purposes of making such computation, the Holder shall be deemed to own the number of Shares
issued or issuable upon conversion of all its Preferred Shares. Holders may exercise such rights
of co-sale by giving written notice to the Selling Principal Shareholder within ten (10) days after
the date of the Selling Principal Shareholder’s Notice, specifying the number of Shares which the
Holder desires to transfer to the Selling Principal Shareholder’s proposed transferee, in which
case the number of Offered Shares which the Selling Principal Shareholder may sell pursuant to the
Selling Principal Shareholder’s Notice shall be correspondingly reduced.
(2) The Holder may effectuate its right of co-sale contemplated by this Section 15 by
delivering to the Selling Principal Shareholder for transfer to the proposed transferee one or more
certificates, properly endorsed for transfer, which represent:
i. the number of Common Shares which the Holder is entitled to, and elects to, sell pursuant
to this Section 15; or
ii. that number of Preferred Shares which is at such time convertible into the number of
Common Shares which such Holder elects to sell pursuant to this Section 15; provided, however, that
if the proposed transferee objects to the delivery of Preferred Shares in lieu of Common Shares,
the Holder may convert and deliver Common Shares as provided in subparagraph 15.2(2)i above.
13
15.6.1 The price per share at which the Shares are to be sold to any such Principal
Shareholder shall be equal to the price per share paid by the purchaser to such Principal
Shareholder in the Prohibited Transfer. Such Principal Shareholder shall also reimburse the Holder
for any and all reasonable fees and expenses, including attorneys’ fees and expenses, incurred
pursuant to any exercise of the Holder’s rights under this Section 15.6.
15.6.2 Within 90 days after the earlier of the dates on which the Holder (i) received notice
from such Principal Shareholder of the Prohibited Transfer, or (ii) otherwise obtained actual
knowledge of the Prohibited Transfer, the Holder shall, if exercising the put option created
hereby, deliver to such Principal Shareholder the certificate or certificates representing Shares
to be sold, each certificate to be properly endorsed for transfer. The failure of the Holder to
exercise the put option in such 90-day period shall constitute a waiver of the Holder’s right under
this Section 15.6.
15.6.3 Such Principal Shareholder shall, upon receipt of the certificate or certificates for
the Shares to be sold by the Holder, pursuant to Section 15.6.2, pay the aggregate purchase price
therefor and the amount of fees and expenses reimbursable under Section 15.6.1, by check or wire
transfer made payable to the order of the Holder.
THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RIGHTS OF CO-SALE
AS SET FORTH IN AN AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT DATED [______ __], 2006, BY AND AMONG THE REGISTERED HOLDER, THE CORPORATION AND OTHERS. COPIES
OF SUCH AGREEMENT MAY BE OBTAINED BY THOSE PERSONS OR ENTITIES HAVING A LEGITIMATE
INTEREST UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.
14
prospectively) only with the written consent of Holders owning a majority of the Preferred
Shares (including shares issuable upon conversion of Preferred Shares) or their permitted
transferees of such rights. Any provision of this Section 15 may be amended or terminated only
with the written consent of (i) the Company; (ii) Holders owning a majority of the Preferred Shares
(including shares issuable upon conversion of Preferred Shares) or their permitted transferees of
such rights, and (iii) the Principal Shareholders holding a majority of the shares of capital stock
of the Company then held by such Principal Shareholders.
15
notice to agree to purchase its pro rata share of the Equity Securities for the price and upon
the terms and conditions specified in the notice by giving written notice to the Company and
stating therein the quantity of Equity Securities to be purchased. If the Holders fail to exercise
in full the rights of first refusal, the Company shall have 90 days thereafter to sell the Equity
Securities in respect of which the Holders’ rights were not exercised, at a price and upon general
terms and conditions no more favorable to the purchasers thereof than specified in the First
Refusal Notice. If the Company has not sold such Equity Securities within 90 days of the date of
the First Refusal Notice, the Company shall not thereafter issue or sell any Equity Securities,
without first offering such securities to the Holders in the manner provided above.
Notwithstanding the foregoing, the Company shall not be required to offer or sell such Equity
Securities to any Holder who would cause the Company to be in violation of applicable federal or
state securities laws by virtue of such offer or sale.
(1) Equity Securities issued pursuant to stock splits, stock dividends or other
recapitalization transactions;
(2) Equity Securities issued to employees, officers, directors, consultants, contractors or
advisors of the Company pursuant to stock purchase or stock option plans or agreements or other
incentive stock arrangements approved by the Board of Directors of the Company;
(3) Equity Securities or convertible debt securities issued to lenders, equipment lessors or
other parties providing goods or services to the Company;
(4) Equity Securities issued in connection with acquisition transactions;
16
(5) Equity Securities issued upon exercise of the Managing Dealer Warrants;
(6) Equity Securities issued in strategic partnership transactions;
(7) Any shares of the Series A Preferred, Series B Preferred or Series C Preferred; and
(8) Equity Securities issued in any other transaction in which exemption from the right of
first refusal provisions of this Section 16 is approved by the Holders of a majority of the then
outstanding Preferred Shares.
(a) Series A. Each Investor who now holds or hereafter acquires any shares of the
Series A Preferred hereby agrees that, in the event of an Initial Public Offering or Change of
Control, such Investor shall (i) take all such action as may be requested by the Company to
facilitate the amendment of the Articles of Incorporation of the Company so as to remove the rights
of the Series A Preferred Holders to elect the Series A Director; (ii) not exercise its right to
elect the Series A Director as provided for in the Company’s Articles of Incorporation; and (iii)
take all such action as may be requested by the Company to remove the Series A Director, if any,
then serving on the Board.
(b) Series B. Each Investor who now holds or hereafter acquires any shares of the
Series B Preferred hereby agrees that, in the event of an Initial Public Offering or Change of
Control, such Investor shall (i) take all such action as may be requested by the Company to
facilitate the amendment of the Articles of Incorporation of the Company so as to remove the rights
of the Series B Preferred Holders to elect the Series B Director; (ii) not exercise its right to
elect the Series B Director as provided for in the Company’s Articles of Incorporation; and (iii)
take all such action as may be requested by the Company to remove the Series B Director, if any,
then serving on the Board.
17
THE SHARES EVIDENCED HEREBY ARE SUBJECT TO CERTAIN VOTING RESTRICTIONS AS SET FORTH
IN AN AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT DATED [_______ __], 2006, BY
AND AMONG THE REGISTERED HOLDER, THE CORPORATION AND OTHERS (A COPY OF WHICH MAY BE
OBTAINED FROM THE COMPANY) AND BY ACCEPTING ANY INTEREST IN SUCH SHARES, THE PERSON
HOLDING SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BE BOUND BY ALL THE
PROVISIONS OF SAID AGREEMENT.
18. Governing Law; Jurisdiction and Venue. This Agreement shall be governed in all
respects by the internal laws of the State of California, without giving effect to principles of
conflicts of laws. The Parties submit to the jurisdiction of the Courts of the County of Orange,
State of California, or a Federal Court empanelled in the State of California for the resolution of
all legal disputes arising under the terms of this Agreement.
18
of such Existing Investor as set forth on the signature page to the Prior Agreement; (c) if to
a Principal Shareholder, to the address of such Principal Shareholder as set forth on the books and
records of the Company; and (d) if to the Company, to the address set forth on the signature page
hereto; or in all cases, at such other address as a Party may designate by ten (10) days’ advance
written notice to the other Parties pursuant to the provisions of this Section 20.
19
[Signature Page Follows]
20
IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors Rights
Agreement as of the date first set forth above.
OCULUS INNOVATIVE SCIENCES, INC. | ||||
By:
|
||||
Name:
|
||||
Title:
|
||||
Address:
|
0000 Xx. XxXxxxxx Xxxx. | |||
Xxxxxxxx, XX 00000 | ||||
Fax No.:
|
000-000-0000 |
INVESTORS | PRINCIPAL SHAREHOLDERS | |||||||||
By:
|
By: | |||||||||
Print Name:
|
Print Name: | |||||||||
Title:
|
||||||||||
BROOKSTREET SECURITIES | HOLDERS OF MANAGING | |||||||||
CORPORATION | DEALER WARRANTS | |||||||||
(for purposes of Sections 2-12 only) | (for purposes of Sections 2-12 only) | |||||||||
By:
|
By: | |||||||||
Print Name:
|
Print Name: | |||||||||
Title:
|
Title: | |||||||||
[SIGNATURE PAGE TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT]
21
SCHEDULE A
New Investors
Name | Address and Fax Number | |
SCHEDULE B
Principal Shareholders
Xxxxxxx Xxxx
Xxxxxx Xxxxx
Xxxxxxx Xxxxxx
Xxxx Xxxxxx
Xxxxxx Xxxxx
Xxxxxxx Xxxxxx
Xxxx Xxxxxx